Why the study?
Does stopping antiplatelet therapy increase cardiovascular complications in patients with coronary stents undergoing non-cardiac surgery?
Does stopping antiplatelet therapy increase cardiovascular complications in patients with coronary stents undergoing non-cardiac surgery?
Answers are grounded in this paper and cite their sources.
This commentary highlights the high risk of cardiovascular complications, particularly stent thrombosis, when stopping antiplatelet therapy before non-cardiac surgery in patients with coronary stents.
Commentary on: Albaladejo P, Marret E, Samama CM, et al. Non-cardiac surgery in patients with coronary stents: the RECO study. Heart 2011;97:1566–72.[OpenUrl][1][Abstract/FREE Full Text][2] The use of stents in percutaneous coronary intervention (PCI) increases procedural success and decreases restenosis, but it complicates subsequent surgical procedures in these patients.1 Between 5% and 15% of PCI patients undergo non-cardiac surgery in the year following PCI, and are at high risk of experiencing cardiovascular (CV) complications.2 The most serious risk is stent thrombosis, which occurs in 2.5% of patients and is fatal in 40%.3 Although guidelines for the management of these patients are available, the evidence supporting them is lacking.4 Key questions remain regarding contemporary … [1]: {openurl}?query=rft.jtitle%253DHeart%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fhrt.2011.224519%26rft_id%253Dinfo%253Apmid%252F21791513%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/ijlink?linkType=ABST&journalCode=heartjnl&resid=97/19/1566&atom=%2Febmed%2F17%2F4%2F122.atom
No takes yet. Share an insight, caveat, or question.
Thomas M. Maddox (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: